Trial intelligence / Profile preview

Fresh Frozen Plasma (FFP) in Moderate to Severe Traumatic Brain Injury (TBI)

NCT06062888Phase 3Recruiting

Sponsor
Northwestern University
Start
Feb 2026
Primary completion
Aug 2028
Modality
Recombinant Proteins and Enzymes, Tissue Cells
Countries
1
01

Overview

Phase 3, randomised trial in traumatic brain injury (TBI) comparing Standard of Care with Standard of Care + FFP (2 arms). Primary endpoint: Extended Glasgow Outcome Scale at 6 months. Started Feb 2026; status: recruiting.

02

Drugs

fresh-frozen plasma
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT06062888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06062888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call